Microbial biomarker discovery in Parkinson’s disease through a network-based approach Zhe Zhao Jing Chen Junliang Yuan ArticleOpen Access26 Oct 2024 Randomized crossover trial on motor and non-motor outcome of directional deep brain stimulation in Parkinson’s disease ...
Parkinson's disease is a progressive neurodegenerative disorder, which is characterized by motor symptoms such as tremor, rigidity, slowness of movement and problems with gait. Motor symptoms are often accompanied with fatigue, depression, pain and cognitive problems. Latest Research and Reviews Changes...
Parkinson Disease ResearchParkinson disease is the second most common neurodegenerative disorder and the most common...National Institute of Environmental Health SciencesEnvironmental Health Perspectives
ScienceDirect is phasing out support for older versions of Internet Explorer on Jan 12, 2016. For the best product experience, we recommend you upgrade to a newer version of IE or use a different browser: Firefox or Chrome. For additional information please see the ScienceDirect Blog page. ...
American Journal of Physical Medicine & Rehabilitation
(1)细节理解题。根据第一段的Researchers note that what is challenging to cure such patients is that early signs of Parkinson's .disease are not easy to identify(研究人员指出,治疗这类患者的挑战在于帕金森病的早期症状不易识别。)可知,治疗帕金森氏症的障
parkinson's disease research - relevant measures in pre-clinical studies posted by gonny smit on tue 05 mar. 2019 - 4 minute read parkinson's disease: the neurodegenerative disorder that affects mobility in a life-changing way. slow movement, shuffling of the feet, and difficulties initiating ...
Cryo EM is guiding Parkinson's disease research by revealing the structure of LRRK2, a protein linked to genetically inherited Parkinson’s disease.
In this paper, we explore the use of facial expression recognition via artificial intelligence to diagnose a typical neurological system disease, Parkinson disease (PD). Objective: This study proposes methods to diagnose PD through facial expression recognition. Methods: We collected videos of facial ...
ArticleOpen Access08 Oct 2024 Sustained effect of prasinezumab on Parkinson’s disease motor progression in the open-label extension of the PASADENA trial Individuals with Parkinson’s disease treated with prasinezumab demonstrated slower motor progression over 4 years compared with an external comp...